BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced that Dr. Sennewald Medizintechnik GmbH (Medizintechnik) has purchased BSD Medical's BSD-2000/3D/MR Hyperthermia System (BSD-2000/3D/MR). This BSD-2000/3D/MR system is an integration of BSD's advanced regional hyperthermia system with a Magnetic Resonance (MR) Imaging System from Siemens Healthcare. This BSD-2000/3D/MR System is equipped with an innovative array of MR compatible applicators: the Sigma Eye MR applicator for the treatment of adults, the Sigma 40 MR applicator for the treatment of small adults and older children, and the Sigma 30 MR applicator for the treatment of younger children down to the age of 3.
The BSD-2000/3D/MR is an integration of the world's most sophisticated hyperthermia therapy system with magnetic resonance imaging. It introduces a revolutionary new use of magnetic resonance imaging, expanding MRI utilization from its traditional role in diagnostic imaging to real-time imaging and monitoring of cancer treatments. The magnetic resonance images are color graded to show temperature changes in the treatment area during hyperthermia therapy. The BSD-2000/3D/MR System was developed in a collaborative effort with Siemens Healthcare AG, Erlangen, Germany. The BSD-2000/3D/MR has received CE Marking approval.
Social media reshapes children’s diets and body image with alarming consequences